CellSine

Andreas Vesaliusstraat 5 B301

3000 Leuven

BE

CellSine

Foundation date

01/12/2015

Sector

#Biotechnology / R&D Services

Subsector

CellSine was founded in 2015 as a spin-off company from KU Leuven and VUB. We offer instruments and services based on advanced electrochemical impedance spectroscopy for drug discovery and other biomedical applications. The proprietary I-series devices allow you to perform broad-spectrum impedance measurements. Such measurements enable the detection of a wide range of biological phenomena without the use of chemical labels.The latter aspect enables you to design your own high content analyses of living cells in a matter of weeks. The “light” structure of the resulting “big”data is ideal for ultimate exploration with artificial intelligence methods, machine learning, and many other data processing tools.

Upcoming events

Latest news

  • Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies

    13 hours ago

  • Indigo Diabetes announces first participant enrolled in the SHINE clinical trial

    Thursday September 29th 2022

  • FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome

    Tuesday September 27th 2022